logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

R/R B-cell malignancies: novel PI3Kδ inhibitor delivers high response

Low hepatotoxicity in phase 1/2 trial attributed to novel structure.